Section Arrow
Quote
HBIO.NASDAQ
- Harvard Bioscience Inc.
Quotes are at least 15-min delayed:2026/04/03 19:51 EDT
Regular Hours
Last
 5.2
+0.11 (+2.16%)
Day High 
5.2699 
Prev. Close
5.09 
1-M High
6.199 
Volume 
31.04K 
Bid
5
Ask
5.4
Day Low
5 
Open
5 
1-M Low
4 
Market Cap 
227.62M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.1 
20-SMA 5.1 
50-SMA 5.42 
52-W High 9.458 
52-W Low 2.813 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.28/0.36
Enterprise Value
270.38M
Balance Sheet
Book Value Per Share
3.07
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
86.55M
Operating Revenue Per Share
2.52
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc44.28+0.28+0.64%30.21PE
BAXBaxter International16.68-0.1-0.60%-- 
AVTRAvantor7.9+0.13+1.67%-- 
HOLXHologic75.65+0.05+0.07%31.37PE
XRAYDENTSPLY SIRONA11.63-0.03-0.26%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.